Q&A: COVID-19 Infectiousness Peaks Early in Sickness, Study Shows

Patients’ viral loads are highest within five days of their first symptoms, emphasizing the need to isolate early to prevent transmission.

Written byMax Kozlov
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

ABOVE: © ISTOCK.COM,
JORDANSIMEONOV

Since early March, a number of studies have suggested that patients infected with SARS-CoV-2 generally have a long incubation period and are most infectious early on in their sickness, with viral loads dropping off after nine days. These results have informed guidelines put forth by public health bodies, such as the US Centers for Disease Control and Prevention, which recommend that people isolate for at least 10 days following a positive COVID-19 test.

A meta-analysis published November 19 in The Lancet Microbe reviewed 98 studies on coronaviruses—79 of which focused on SARS-CoV-2 and the rest on SARS-CoV and MERS-CoV—to determine when patients’ viral loads are highest and could therefore transmit the virus most effectively. Of the SARS-CoV-2 studies, 73 included hospitalized patients only.

Their report finds that patients with COVID-19 show the highest amount of live virus in the upper respiratory tract within the first five days ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Max is a science journalist from Boston. Though he studied cognitive neuroscience, he now prefers to write about brains rather than research them. Prior to writing for The Scientist as an editorial intern in late 2020 and early 2021, Max worked at the Museum of Science in Boston, where his favorite part of the job was dressing in a giant bee costume and teaching children about honeybees. He was also a AAAS Mass Media Fellow, where he worked as a science reporter for the St. Louis Post-Dispatch. Read more of his work at www.maxkozlov.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies